Apr 10, 2017
Cancer drug Kadcyla approved for use by NHS Scotland
Kadcyla is used to treat an aggressive, advanced type of breast cancer known as HER2 positive. The drug will be removed from the NHS south of the border in June - a decision which has prompted a fierce backlash from breast cancer patients and campaign groups. In Scotland, Breast Cancer Now said they worked alongside four "Inspirational" women - all with incurable secondary breast cancer - who led the "Unlock Kadcyla" campaign. The charity's director for Scotland, Mary Allison, said: "This decision will transform treatment options for women with HER2 positive secondary breast cancer in Scotland." What is Kadcyla and what does it do? Kadcyla is used to treat breast cancer which has spread to other parts of the body.
Make a complaint about NHS Scotland by viewing their customer service contacts.